Please note: this site relies heavily on the use of javascript. Without a javascript-enabled browser, this site will not function correctly. Please enable javascript and reload the page, or switch to a different browser.
4  structures 609  species 1  interaction 927  sequences 20  architectures

Family: MIOX (PF05153)

Summary: Myo-inositol oxygenase

Pfam includes annotations and additional family information from a range of different sources. These sources can be accessed via the tabs below.

This is the Wikipedia entry entitled "Inositol oxygenase". More...

Inositol oxygenase Edit Wikipedia article

myo-inositol oxygenase
Mouse miox.png
Structure of the mouse myo-inositol oxygenase monomer, generated from 2HUO, colored by secondary structure element.
Identifiers
Symbol MIOX
Alt. symbols ALDRL6
Entrez 55586
HUGO 14522
OMIM 606774
PDB 2IBN
RefSeq NM_017584
UniProt Q9UGB7
Other data
EC number 1.13.99.1
Locus Chr. 22 q

Inositol oxygenase, also commonly referred to as myo-inositol oxygenase (MIOX), is a non-heme di-iron enzyme that oxidizes myo-inositol to glucuronic acid.[1] The enzyme employs a unique four-electron transfer at its Fe(II)/Fe(III) coordination sites and the reaction proceeds through the direct binding of myo-inositol followed by attack of the iron center by diatomic oxygen. This enzyme is part of the only known pathway for the catabolism of inositol in humans[2] and is expressed primarily in the kidneys.[3][4] Recent medical research regarding MIOX has focused on understanding its role in metabolic and kidney diseases such as diabetes, obesity and acute kidney injury. Industrially-focused engineering efforts are centered on improving MIOX activity in order to produce glucaric acid in heterologous hosts.

Structure

The active site of the mouse MIOX enzyme highlighting the di-iron active site along with the coordinated amino acids. The Fe atom binds to the oxygens of the C1 and C6 of myo-inositol. Lys 127 helps to promote the abstraction of the hydrogen atom from the C1 carbon.

Myo-inositol oxygenase is a monomeric 33 kDa protein in both solution and crystal.[5] This enzyme possesses a Fe(II)/Fe(III) atomic pair at the catalytic active site which enables its unique four-electron transfer mechanism. Recent crystallization studies have elucidated the structures of the mouse MIOX [5] in 2006 followed by the human MIOX[6] in 2008.

The overall structure of the mouse MIOX is primarily helical with five alpha helices forming the core of the protein.[5] Like other di-iron oxygenases, the iron coordination centers are buried deep inside the protein presumably to protect the cell from the superoxide and radical reaction intermediates that are formed.[7] The two iron centers are coordinated by various amino acids and water molecules as shown in complex with the myo-inositol substrate. The human MIOX structure superimposes closely onto the mouse MIOX structure, sharing 86% sequence identity over the structural alignment but with some differences in the residues surrounding the active site.[6] The human enzyme is characterized by eight alpha helices and a small anti-parallel two-stranded beta sheet.[6]

the MIOX protein fold diverges from that of other non-heme di-iron oxygenases including ribonucleotide reductase and soluble methane monooxygenase.[8] Instead, MIOX closely resembles proteins in the HD-domain superfamily based on its highly conserved metal binding strategy and the presence of the four His ligands on the iron center.[5]

Mechanism

MIOX can accept D-myo-inositol as well as the less abundant chiro isomer of inositol as substrates.[9] A series of crystallization, spectroscopy and density functional theory experiments have revealed a putative mechanism (shown right) for the oxidation of myo-inositol.[10][11][12] ENDOR spectroscopy was used to determine that the substrate directly binds to the Fe(II)/Fe(III) di-iron center of MIOX most likely through the O1 atom of myo-inositol.[7] In the mouse MIOX, this binding process was shown to be dependent on proximal amino acid residues as alanine mutants D85A and K127A were unable to turnover substrate.[5] This binding step positions the myo-inositol prior to the catalytic steps which involve attack of an iron center by diatomic oxygen followed by abstraction of a myo-inositol hydrogen atom.

A superoxide Fe(III)/Fe(III) species is formed as diatomic oxygen displaces water as a coordinating ligand on one of the Fe atoms. Next, the hydrogen atom from C1 of myo-inositol is abstracted to generate a radical that can be attacked by an oxygen radical. Release of D-glucuronic acid is achieved in the fourth step.

Biological Function

Myo-inositol can be ingested from fruits and vegetables and actively transported into cells or instead directly synthesized from glucose.[13] In the kidney, MIOX converts myo-inositol to glucuronic acid which is then able to enter the glucuronate-xylulose pathway for conversion to xylulose-5-phosphate.[13] This product can then easily enter the pentose phosphate pathway. Hence, MIOX enables the conversion and catabolism of inositol to generate NADPH and other pentose sugars.

Disease Relevance.

Myo-inositol is a component of the inositol phosphates and phosphoinositides that serve as secondary messengers in many cellular processes including insulin action. Due to its exclusive expression in the kidney, research has focused on understanding the potential role of both myo-inositol levels and MIOX activity on metabolic diseases like diabetes mellitus and obesity. Depletion of MIOX and accumulation of polyols, such as inositol and xylitol, have been cited as contributing factors in complications associated with diabetes.[14] Additionally, a recent study has shown that MIOX is upregulated in the diabetic state with its transcription heavily regulated by osmolarity, glucose levels and oxidative stress.[15] This upregulation is associated with the formation of reactive oxidative species that lead to interstitial injury in the kidney.[15]

There is also interest in evaluating MIOX expression as a potential biomarker of acute kidney injury. MIOX expression was shown to increase in the serum of animals and plasma of critically ill patients within 24 hours of acute kidney injury specifically.[16] An immunoassay of MIOX expression may potentially predict these life-threatening injuries earlier than the current diagnostic—detection of plasma creatine.

Industrial Relevance

The MIOX enzyme has been the object of intense metabolic engineering efforts to produce glucaric acid through biosynthetic pathways. In 2004, the U.S. Department of Energy released a list of the top value-added chemicals from biomass which included glucaric acid—the direct product of the oxidation of glucuronic acid. The first biosynthetic production of glucaric acid was achieved in 2009 with use of the uronate dehydrogenase (UDH) enzyme.[17] Since then, the MIOX enzyme has been engineered for improved glucaric acid production through numerous strategies including appendage of an N-terminal SUMO-tag, directed evolution[18] and also the use of modular, synthetic scaffolds to increase its effective local concentration.

The conversion of myo-inositol to glucaric acid--a top value-added chemical from biomass--can be achieved with a combination of MIOX and UDH enabling heterologous production of glucaric acid.

See also

References

  1. ^ Bollinger JM, Diao Y, Matthews ML, Xing G, Krebs C (February 2009). "myo-Inositol oxygenase: a radical new pathway for O(2) and C-H activation at a nonheme diiron cluster". Dalton Transactions (6): 905–14. doi:10.1039/b811885j. PMC 2788986 Freely accessible. PMID 19173070. 
  2. ^ Hankes LV, Politzer WM, Touster O, Anderson L (October 1969). "Myo-inositol catabolism in human pentosurics: the predominant role of the glucuronate-xylulose-pentose phosphate pathway". Annals of the New York Academy of Sciences. 165 (2): 564–76. doi:10.1111/j.1749-6632.1970.tb56424.x. PMID 5259614. 
  3. ^ Reddy CC, Swan JS, Hamilton GA (August 1981). "myo-Inositol oxygenase from hog kidney. I. Purification and characterization of the oxygenase and of an enzyme complex containing the oxygenase and D-glucuronate reductase". The Journal of Biological Chemistry. 256 (16): 8510–8. PMID 7263666. 
  4. ^ Charalampous FC (February 1959). "Biochemical studies on inositol. V. Purification and properties of the enzyme that cleaves inositol to D-glucuronic acid". The Journal of Biological Chemistry. 234 (2): 220–7. PMID 13630882. 
  5. ^ a b c d e Brown PM, Caradoc-Davies TT, Dickson JM, Cooper GJ, Loomes KM, Baker EN (October 2006). "Crystal structure of a substrate complex of myo-inositol oxygenase, a di-iron oxygenase with a key role in inositol metabolism". Proceedings of the National Academy of Sciences of the United States of America. 103 (41): 15032–7. doi:10.1073/pnas.0605143103. PMC 1622774 Freely accessible. PMID 17012379. 
  6. ^ a b c Thorsell AG, Persson C, Voevodskaya N, Busam RD, Hammarström M, Gräslund S, Gräslund A, Hallberg BM (May 2008). "Structural and biophysical characterization of human myo-inositol oxygenase". The Journal of Biological Chemistry. 283 (22): 15209–16. doi:10.1074/jbc.M800348200. PMC 3258897 Freely accessible. PMID 18364358. 
  7. ^ a b Kim SH, Xing G, Bollinger JM, Krebs C, Hoffman BM (August 2006). "Demonstration by 2H ENDOR spectroscopy that myo-inositol binds via an alkoxide bridge to the mixed-valent diiron center of myo-inositol oxygenase". Journal of the American Chemical Society. 128 (32): 10374–5. doi:10.1021/ja063602c. PMID 16895396. 
  8. ^ Hirao H, Morokuma K (December 2009). "Insights into the (superoxo)Fe(III)Fe(III) intermediate and reaction mechanism of myo-inositol oxygenase: DFT and ONIOM(DFT:MM) study". Journal of the American Chemical Society. 131 (47): 17206–14. doi:10.1021/ja905296w. PMID 19929019. 
  9. ^ Arner RJ, Prabhu KS, Thompson JT, Hildenbrandt GR, Liken AD, Reddy CC (December 2001). "myo-Inositol oxygenase: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol". The Biochemical Journal. 360 (Pt 2): 313–20. doi:10.1042/0264-6021:3600313. PMC 1222231 Freely accessible. PMID 11716759. 
  10. ^ Xing G, Barr EW, Diao Y, Hoffart LM, Prabhu KS, Arner RJ, Reddy CC, Krebs C, Bollinger JM (May 2006). "Oxygen activation by a mixed-valent, diiron(II/III) cluster in the glycol cleavage reaction catalyzed by myo-inositol oxygenase". Biochemistry. 45 (17): 5402–12. doi:10.1021/bi0526276. PMID 16634621. 
  11. ^ Xing G, Hoffart LM, Diao Y, Prabhu KS, Arner RJ, Reddy CC, Krebs C, Bollinger JM (May 2006). "A coupled dinuclear iron cluster that is perturbed by substrate binding in myo-inositol oxygenase". Biochemistry. 45 (17): 5393–401. doi:10.1021/bi0519607. PMID 16634620. 
  12. ^ Xing G, Diao Y, Hoffart LM, Barr EW, Prabhu KS, Arner RJ, Reddy CC, Krebs C, Bollinger JM (April 2006). "Evidence for C-H cleavage by an iron-superoxide complex in the glycol cleavage reaction catalyzed by myo-inositol oxygenase". Proceedings of the National Academy of Sciences of the United States of America. 103 (16): 6130–5. doi:10.1073/pnas.0508473103. PMC 1458843 Freely accessible. PMID 16606846. 
  13. ^ a b Croze ML, Soulage CO (October 2013). "Potential role and therapeutic interests of myo-inositol in metabolic diseases". Biochimie. 95 (10): 1811–27. doi:10.1016/j.biochi.2013.05.011. PMID 23764390. 
  14. ^ Cohen RA, MacGregor LC, Spokes KC, Silva P, Epstein FH (October 1990). "Effect of myo-inositol on renal Na-K-ATPase in experimental diabetes". Metabolism. 39 (10): 1026–32. doi:10.1016/0026-0495(90)90161-5. PMID 2170818. 
  15. ^ a b Tominaga T, Dutta RK, Joladarashi D, Doi T, Reddy JK, Kanwar YS (January 2016). "Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: Implications in Renal Tubular Injury Induced in Obesity and Diabetes". The Journal of Biological Chemistry. 291 (3): 1348–67. doi:10.1074/jbc.M115.698191. PMC 4714220 Freely accessible. PMID 26578517. 
  16. ^ Gaut JP, Crimmins DL, Ohlendorf MF, Lockwood CM, Griest TA, Brada NA, Hoshi M, Sato B, Hotchkiss RS, Jain S, Ladenson JH (May 2014). "Development of an immunoassay for the kidney-specific protein myo-inositol oxygenase, a potential biomarker of acute kidney injury". Clinical Chemistry. 60 (5): 747–57. doi:10.1373/clinchem.2013.212993. PMC 4128578 Freely accessible. PMID 24486646. 
  17. ^ Moon TS, Yoon SH, Lanza AM, Roy-Mayhew JD, Prather KL (February 2009). "Production of glucaric acid from a synthetic pathway in recombinant Escherichia coli". Applied and Environmental Microbiology. 75 (3): 589–95. doi:10.1128/AEM.00973-08. PMC 2632142 Freely accessible. PMID 19060162. 
  18. ^ Shiue E, Prather KL (March 2014). "Improving D-glucaric acid production from myo-inositol in E. coli by increasing MIOX stability and myo-inositol transport". Metabolic Engineering. 22: 22–31. doi:10.1016/j.ymben.2013.12.002. PMID 24333274. 

External links

This page is based on a Wikipedia article. The text is available under the Creative Commons Attribution/Share-Alike License.

This tab holds the annotation information that is stored in the Pfam database. As we move to using Wikipedia as our main source of annotation, the contents of this tab will be gradually replaced by the Wikipedia tab.

Myo-inositol oxygenase Provide feedback

MIOX is the enzyme myo-inositol oxygenase. It catalyses the first committed step in the glucuronate-xylulose pathway, It is a di-iron oxygenase with a key role in inositol metabolism. The structure reveals a monomeric, single-domain protein with a mostly helical fold that is distantly related to the diverse HD domain superfamily. The structural core is of five alpha-helices that contribute six ligands, four His and two Asp, to the di-iron centre where the two iron atoms are bridged by a putative hydroxide ion and one of the Asp ligands. The substrate is myo-inositol is bound in a terminal substrate-binding mode to a di-iron cluster [1]. Within the structure are two additional proteinous lids that cover and shield the enzyme's active site [2].

Literature references

  1. Brown PM, Caradoc-Davies TT, Dickson JM, Cooper GJ, Loomes KM, Baker EN;, Proc Natl Acad Sci U S A. 2006;103:15032-15037.: Crystal structure of a substrate complex of myo-inositol oxygenase, a di-iron oxygenase with a key role in inositol metabolism. PUBMED:17012379 EPMC:17012379

  2. Thorsell AG, Persson C, Voevodskaya N, Busam RD, Hammarstrom M, Graslund S, Graslund A, Hallberg BM;, J Biol Chem. 2008;283:15209-15216.: Structural and biophysical characterization of human myo-inositol oxygenase. PUBMED:18364358 EPMC:18364358

Internal database links

SCOOP: HD

This tab holds annotation information from the InterPro database.

InterPro entry IPR007828

Inositol oxygenase (EC) is involved in the biosynthesis of UDP-glucuronic acid (UDP-GlcA), providing nucleotide sugars for cell-wall polymers. It may be also involved in plant ascorbate biosynthesis [PUBMED:15660207, PUBMED:14976233].

Gene Ontology

The mapping between Pfam and Gene Ontology is provided by InterPro. If you use this data please cite InterPro.

Cellular component cytoplasm (GO:0005737)
Molecular function iron ion binding (GO:0005506)
inositol oxygenase activity (GO:0050113)
Biological process inositol catabolic process (GO:0019310)
oxidation-reduction process (GO:0055114)

Domain organisation

Below is a listing of the unique domain organisations or architectures in which this domain is found. More...

Loading domain graphics...

Pfam Clan

This family is a member of clan HD_PDEase (CL0237), which has the following description:

This clan includes a range of phosphohydrolase enzymes with a common helical fold.

The clan contains the following 10 members:

HD HD_2 HD_3 HD_4 HD_5 HDOD MIOX PDEase_I TraI_2 tRNA_NucTran2_2

Alignments

We store a range of different sequence alignments for families. As well as the seed alignment from which the family is built, we provide the full alignment, generated by searching the sequence database (reference proteomes) using the family HMM. We also generate alignments using four representative proteomes (RP) sets, the UniProtKB sequence database, the NCBI sequence database, and our metagenomics sequence database. More...

View options

We make a range of alignments for each Pfam-A family. You can see a description of each above. You can view these alignments in various ways but please note that some types of alignment are never generated while others may not be available for all families, most commonly because the alignments are too large to handle.

  Seed
(20)		 Full
(927)		 Representative proteomes UniProt
(1356)		 NCBI
(2068)		 Meta
(190)
RP15
(177)		 RP35
(459)		 RP55
(709)		 RP75
(910)
Jalview View  View  View  View  View  View  View  View  View 
HTML View  View               
PP/heatmap 1 View               

1Cannot generate PP/Heatmap alignments for seeds; no PP data available

Key: ✓ available, x not generated, — not available.

Format an alignment

  Seed
(20)		 Full
(927)		 Representative proteomes UniProt
(1356)		 NCBI
(2068)		 Meta
(190)
RP15
(177)		 RP35
(459)		 RP55
(709)		 RP75
(910)
Alignment:
Format:
Order:
Sequence:
Gaps:
Download/view:

Download options

We make all of our alignments available in Stockholm format. You can download them here as raw, plain text files or as gzip-compressed files.

  Seed
(20)		 Full
(927)		 Representative proteomes UniProt
(1356)		 NCBI
(2068)		 Meta
(190)
RP15
(177)		 RP35
(459)		 RP55
(709)		 RP75
(910)
Raw Stockholm Download   Download   Download   Download   Download   Download   Download   Download   Download  
Gzipped Download   Download   Download   Download   Download   Download   Download   Download   Download  

You can also download a FASTA format file containing the full-length sequences for all sequences in the full alignment.

HMM logo

HMM logos is one way of visualising profile HMMs. Logos provide a quick overview of the properties of an HMM in a graphical form. You can see a more detailed description of HMM logos and find out how you can interpret them here. More...

Trees

This page displays the phylogenetic tree for this family's seed alignment. We use FastTree to calculate neighbour join trees with a local bootstrap based on 100 resamples (shown next to the tree nodes). FastTree calculates approximately-maximum-likelihood phylogenetic trees from our seed alignment.

Note: You can also download the data file for the tree.

Curation and family details

This section shows the detailed information about the Pfam family. You can see the definitions of many of the terms in this section in the glossary and a fuller explanation of the scoring system that we use in the scores section of the help pages.

Curation View help on the curation process

Seed source: Pfam-B_2804 (release 7.7)
Previous IDs: DUF706;
Type: Family
Author: Finn RD
Number in seed: 20
Number in full: 927
Average length of the domain: 224.90 aa
Average identity of full alignment: 50 %
Average coverage of the sequence by the domain: 76.32 %

HMM information View help on HMM parameters

HMM build commands:
build method: hmmbuild -o /dev/null HMM SEED
search method: hmmsearch -Z 26740544 -E 1000 --cpu 4 HMM pfamseq
Model details:
Parameter Sequence Domain
Gathering cut-off 20.6 20.6
Trusted cut-off 20.6 20.6
Noise cut-off 20.5 20.5
Model length: 249
Family (HMM) version: 14
Download: download the raw HMM for this family

Species distribution

Sunburst controls

Hide

Weight segments by...

Change the size of the sunburst

Small
Large

Colour assignments

Archea Archea Eukaryota Eukaryota
Bacteria Bacteria Other sequences Other sequences
Viruses Viruses Unclassified Unclassified
Viroids Viroids Unclassified sequence Unclassified sequence

Selections

Align selected sequences to HMM

Generate a FASTA-format file

Clear selection

This visualisation provides a simple graphical representation of the distribution of this family across species. You can find the original interactive tree in the adjacent tab. More...

Loading sunburst data...

Tree controls

Hide

The tree shows the occurrence of this domain across different species. More...

Loading...

Please note: for large trees this can take some time. While the tree is loading, you can safely switch away from this tab but if you browse away from the family page entirely, the tree will not be loaded.

Interactions

There is 1 interaction for this family. More...

MIOX

Structures

For those sequences which have a structure in the Protein DataBank, we use the mapping between UniProt, PDB and Pfam coordinate systems from the PDBe group, to allow us to map Pfam domains onto UniProt sequences and three-dimensional protein structures. The table below shows the structures on which the MIOX domain has been found. There are 4 instances of this domain found in the PDB. Note that there may be multiple copies of the domain in a single PDB structure, since many structures contain multiple copies of the same protein seqence.

Loading structure mapping...